ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,439Medicare Part D Prescriptions Filled, Including Refills

Rank: 198 out of 1278

$399K Total Retail Price of All Prescriptions

Rank: 215 out of 1278

317 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 317 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

18% of this provider’s 317 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 4,594 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 352 247 1 2
LISINOPRIL 306 222 2 1
HYDROCODONE-ACETAMINOPHEN 301 157 S3 3 7
METFORMIN HCL 227 152 4 4
HYDROCHLOROTHIAZIDE 190 118 5 8
LOVASTATIN 184 115 6 13
GABAPENTIN 183 115 7 12
OMEPRAZOLE 181 128 8 6
POTASSIUM CHLORIDE 174 128 9 21
FUROSEMIDE 167 129 10 10
RANITIDINE HCL 147 68 11 20
AMLODIPINE BESYLATE 141 124 12 5
MORPHINE SULFATE ER 141 52 S2 12 42
FLUOXETINE HCL 138 92 14 41
PROAIR HFA 129 64 15 26
METOPROLOL TARTRATE 127 88 16 9
ATENOLOL 93 62 17 11
OXYCODONE-ACETAMINOPHEN 93 64 S2 17 29
SIMVASTATIN 90 83 19 3
IBUPROFEN 89 38 20 46
ALLOPURINOL 83 66 21 36
CARISOPRODOL 81 46 R 22 51
CYCLOBENZAPRINE HCL 80 28 R 23 62
MORPHINE SULFATE 80 0 S2 23 115
SPIRONOLACTONE 75 36 25 78
GLIPIZIDE 75 39 25 35
OXYBUTYNIN CHLORIDE 73 56 27 80
AMITRIPTYLINE HCL 70 16 R 28 55
TRAZODONE HCL 66 30 29 38
CARVEDILOL 65 64 30 39
TRAMADOL HCL 65 35 30 25
PREDNISONE 59 36 32 52
METOPROLOL SUCCINATE 57 17 33 23
GEMFIBROZIL 57 12 33 54
DOXAZOSIN MESYLATE 55 26 35 69
ZOLPIDEM TARTRATE 55 27 35 16
ATROVENT HFA 55 25 35 201
TERAZOSIN HCL 54 54 38 59
METHOCARBAMOL 53 19 R 39 120
BACLOFEN 52 28 40 113
OXYCODONE HCL-ACETAMINOPHEN 50 18 S2 41 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.